Does Mounjaro Cause Hair Loss in Women?

Step 1: Understand what's actually happening to your hair

Telogen effluvium is the clinical name for a broad category of temporary shedding. Hair follicles cycle through growth and rest phases; a significant physiological stress (surgery, illness, crash dieting, childbirth, or rapid weight loss) can push a larger-than-normal proportion of follicles into the resting (telogen) phase simultaneously. Six to twelve weeks later, those hairs shed together. The result looks alarming in the shower but is not the same as alopecia or permanent thinning.

Mounjaro (tirzepatide) is not listed as a cause of alopecia in the medicine's Summary of Product Characteristics. The NHS tirzepatide information page does not name hair loss among the common adverse effects. What links tirzepatide to shedding is the weight loss itself, losing more than a kilogram a week, eating substantially less, or falling short on protein can all act as triggers. The medicine's effectiveness, in other words, is the indirect cause.

This matters because it changes what a clinician looks for. The relevant questions are how fast weight is coming off, how much protein is in the diet, whether any micronutrient levels (ferritin, thyroid hormones, vitamin D) are low, and whether there are other hormonal factors, all more amenable to practical solutions than stopping the medicine.

Step 2: Check the nutrition picture first

A practical checking habit that takes under a minute: photograph or log your meals for a single day and count whether you're reaching roughly 1.2–1.6 g of protein per kilogram of body weight. Many women on tirzepatide find appetite suppression cuts overall intake so sharply that protein falls away quietly. Shedding that starts around the same time as dramatically reduced eating is a strong signal that diet composition deserves attention before anything else.

Iron stores (specifically ferritin) are a separate and common culprit, particularly in premenopausal women. A GP can order a straightforward blood panel. Low ferritin is correctable with supplementation, and restoring levels often reduces shedding over two to three months. The broader picture of how Mounjaro affects women covers several of these hormonal and nutritional threads in more depth.

Practical steps worth discussing with a prescriber or dietitian: prioritise protein at each meal (eggs, Greek yoghurt, fish, legumes), consider a general multivitamin with B12 and zinc, and avoid very low-calorie days that feel achievable only because appetite is suppressed. The goal is hitting the nutrition targets the medicine's appetite effect may otherwise make easy to miss.

Step 3: When to get medical help

Not all hair loss during Mounjaro treatment is telogen effluvium, and some causes do need prompt assessment. Contact your GP or prescriber if you notice any of the following: patches of baldness rather than diffuse thinning; loss of eyebrow or body hair alongside scalp loss; shedding that is still worsening after six months rather than stabilising; or hair loss accompanied by fatigue, feeling cold, unexplained weight changes, or skin changes that could point to thyroid dysfunction.

If you are taking oral contraceptives alongside tirzepatide, your prescriber should already have discussed contraceptive absorption, the guidance recommends an additional non-oral method for the first four weeks of treatment and for four weeks after each dose increase. Hormonal changes from contraceptive adjustment can occasionally interact with hair cycle independently of weight loss, so flag it if shedding started around the same time as a contraceptive change.

Any suspected side effect (including unexpected hair loss) can be reported directly to the MHRA via the Yellow Card scheme. Reporting builds the post-market evidence base that keeps prescribing guidance current. You don't need to be certain the medicine is the cause; a suspicion is enough to file a report.

Step 4: What usually happens over time

For most women, shedding from telogen effluvium peaks around three to four months after the trigger and then gradually slows. Hair regrowth follows, though it can take six to twelve months before density visibly returns to baseline. The detailed guide to Mounjaro and hair loss in women walks through the evidence on regrowth timelines and which treatments dermatologists consider where shedding is prolonged.

Women who experience persistent or worsening shedding beyond six months should not simply wait it out, a dermatology referral is appropriate at that point. A scalp biopsy or trichoscopy can distinguish telogen effluvium from other diagnoses that need separate treatment. If you are still trying to understand whether Mounjaro actually causes hair loss or want a deeper look at the mechanisms by which Mounjaro causes hair loss, both of those pages set out the evidence in more detail. The key principle: hair loss on tirzepatide is common, usually temporary, and rarely a reason to stop treatment without first exploring the correctable causes. Stopping abruptly without clinical guidance risks regaining weight rapidly, which carries its own health consequences.

For a broader overview of tirzepatide's clinical profile and what it is licensed for, the Mounjaro overview covers eligibility, the weight-loss evidence, and how the medicine works. If cost or access is a consideration, the cost context page explains what a legitimate private prescription includes. Our prescribers discuss side effects, including hair loss concerns, as a routine part of the clinical consultation, and the consultation itself is free.

Start your free consultation to speak to a prescriber about whether tirzepatide is clinically suitable for you.